Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
MousePhenoabnormal inner ear canal fusion

NTN1 CHD7

1.62e-053332MP:0002859
DomainTRYPSIN_SER

PRSS38 TMPRSS11D PRSS22

1.41e-0390463IPR033116
DomainPAS

KCNH6 NCOA3

1.72e-0325462PF00989
DomainPAS_fold

KCNH6 NCOA3

1.72e-0325462IPR013767
DomaincEGF

CD93 LTBP3

1.86e-0326462IPR026823
DomaincEGF

CD93 LTBP3

1.86e-0326462PF12662
DomainTRYPSIN_HIS

PRSS38 TMPRSS11D PRSS22

2.08e-03103463IPR018114
DomainTRYPSIN_SER

PRSS38 TMPRSS11D PRSS22

2.26e-03106463PS00135
DomainTRYPSIN_HIS

PRSS38 TMPRSS11D PRSS22

2.32e-03107463PS00134
DomainPeptidase_S1A

PRSS38 TMPRSS11D PRSS22

2.71e-03113463IPR001314
DomainTRYPSIN_DOM

PRSS38 TMPRSS11D PRSS22

2.85e-03115463PS50240
DomainTryp_SPc

PRSS38 TMPRSS11D PRSS22

2.99e-03117463SM00020
DomainPAS

KCNH6 NCOA3

3.17e-0334462IPR000014
DomainPAS

KCNH6 NCOA3

3.17e-0334462PS50112
DomainTrypsin

PRSS38 TMPRSS11D PRSS22

3.29e-03121463PF00089
DomainTrypsin_dom

PRSS38 TMPRSS11D PRSS22

3.29e-03121463IPR001254
DomainPeptidase_S1_PA

PRSS38 TMPRSS11D PRSS22

3.44e-03123463IPR009003
DomainEGF-like_CS

CD93 ADAM33 NTN1 LTBP3

3.84e-03261464IPR013032
DomainEGF_2

CD93 ADAM33 NTN1 LTBP3

4.05e-03265464PS01186
DomainNAD(P)-bd_dom

SDR42E2 DHRS13 ME1

8.86e-03173463IPR016040
Pubmed

Oxysterol-binding protein-like 7 deficiency leads to ER stress-mediated apoptosis in podocytes and proteinuria.

COL4A3 OSBPL7

5.83e-06349238961844
Pubmed

Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.

CD93 ADSS2 RASGEF1A ABCC9 CFAP418 INCA1 BRAT1 OLFML3

1.68e-0581449823251661
Pubmed

Netrin 1-Mediated Role of the Substantia Nigra Pars Compacta and Ventral Tegmental Area in the Guidance of the Medial Habenular Axons.

GLI2 NTN1

1.94e-05549234169076
Pubmed

Quantitative trait loci affecting the 3D skull shape and size in mouse and prioritization of candidate genes in-silico.

CD93 GLI2 CHD7

2.32e-053949325859222
Pubmed

The morphogen sonic hedgehog is an axonal chemoattractant that collaborates with netrin-1 in midline axon guidance.

GLI2 NTN1

2.91e-05649212679031
Pubmed

Ventral midline cells are required for the local control of commissural axon guidance in the mouse spinal cord.

GLI2 NTN1

2.91e-05649210409510
Pubmed

Molecular control of spinal accessory motor neuron/axon development in the mouse spinal cord.

GLI2 NTN1

5.42e-05849216267219
Pubmed

Short amino acid sequences derived from C1q receptor (C1q-R) show homology with the alpha chains of fibronectin and vitronectin receptors and collagen type IV.

COL4A3 CD93

5.42e-0584921377218
Pubmed

Analysis of candidate genes on chromosome 2 in oral cleft case-parent trios from three populations.

COL4A3 GLI2

6.96e-05949216953426
Pubmed

Interaction between Alzheimer's disease beta A4 precursor protein (APP) and the extracellular matrix: evidence for the participation of heparan sulfate proteoglycans.

COL4A3 CD93

8.69e-05104929136074
Pubmed

Developmental guidance of the retroflex tract at its bending point involves Robo1-Slit2-mediated floor plate repulsion.

GLI2 NTN1

1.50e-041349225366972
Pubmed

Dorsally derived netrin 1 provides an inhibitory cue and elaborates the 'waiting period' for primary sensory axons in the developing spinal cord.

GLI2 NTN1

1.75e-041449216510500
Pubmed

GLI3 repressor controls functional development of the mouse ureter.

GLI2 UPK3B

1.75e-041449221339645
Pubmed

Delayed fusion and altered gene expression contribute to semicircular canal defects in Chd7 deficient mice.

NTN1 CHD7

2.30e-041649222705977
Pubmed

Netrin1 Produced by Neural Progenitors, Not Floor Plate Cells, Is Required for Axon Guidance in the Spinal Cord.

GLI2 NTN1

2.30e-041649228434801
Pubmed

Sensory and spinal inhibitory dorsal midline crossing is independent of Robo3.

GLI2 NTN1

2.61e-041749226257608
Pubmed

Keratin 79 identifies a novel population of migratory epithelial cells that initiates hair canal morphogenesis and regeneration.

GLI2 KRT79

4.01e-042149224198274
Pubmed

The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.

APLN ALKBH7 PRSS22 DHRS13 CHSY1 ADAM33 OLFML3

4.36e-0498549712975309
Pubmed

Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer.

HECTD4 RNF213 BRAT1 ME1

5.26e-0426449432814769
Pubmed

Genetic mapping of mouse transient receptor potential (Trrp) genes responsible for capacitative calcium entry channels to chromosomes 3, 7, 9, and X.

ETFDH ME1

5.26e-04244929722956
Pubmed

A single-cell time-lapse of mouse prenatal development from gastrula to birth.

UPK3B NTN1

5.71e-042549238355799
Pubmed

Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia.

TSPOAP1 ADAM33 LTBP3

6.26e-0411849321078624
Pubmed

Suppressor of fused controls cerebellar neuronal differentiation in a manner modulated by GLI3 repressor and Fgf15.

GLI2 NTN1

8.25e-043049228560839
Pubmed

Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.

COL17A1 TSPYL4 BAHCC1

8.29e-0413049312421765
Pubmed

Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.

ACSL4 ANKRD35 ETFDH GBE1 RNF213 LTBP3 OLFML3 ILVBL

8.84e-04145149830550785
Pubmed

Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus.

COL4A3 CHSY1

1.12e-033549223291589
GeneFamilyProteases, serine

PRSS38 TMPRSS11D PRSS22

1.53e-0463303738
GeneFamilyCollagens

COL4A3 COL17A1

2.63e-0346302490
ToppCellCV-Severe-7|CV / Virus stimulation, Condition and Cluster

CD93 NCOA3 RNF213 CHD7 ME1

1.44e-061764953de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCell(3)_Chondrocytes-(30)_Chondro|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis

CD93 GLI2 CHSY1 ABCC9 OLFML3

2.37e-06195495f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type

COL4A3 CECR2 CHD7 LTBP3 ME1

2.69e-062004952dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCellTracheal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

APLN ABCC9 ADAM33 C1orf167 OLFML3

2.69e-062004953e0041c04e42a47257517dae8707a6454570c256
ToppCellAT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id

COL4A3 APLN UPK3B ABCC9

2.54e-05155494010e45ef4b505bf419ea41e4d1619521d1c78319
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

UPK3B TMPRSS11D PRSS22 MYEOV

3.65e-0517049413a225e32132e9717debb0d64d7c28ada974c3e6
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

GLI2 ABCC9 ADAM33 OLFML3

3.82e-051724941ef243bce63d841c25e4b74d029d1377f84bcc3d
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

GLI2 ABCC9 ADAM33 OLFML3

3.82e-05172494ab1c81be29f93ca8920c6ab5ab92f497a9256d3f
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

APLN ABCC9 ADAM33 OLFML3

4.00e-0517449495464817adef5ad2038bbf542f315756b7ad862e
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

UPK3B TMPRSS11D PRSS22 MYEOV

4.09e-051754948252ddc2ca95071381f0354aefb70c4714828491
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

UPK3B TMPRSS11D PRSS22 MYEOV

4.09e-051754948ccf60fc469059d7aaf4e6ce54159db2962e0060
ToppCellCV-Severe-7|Severe / Virus stimulation, Condition and Cluster

CD93 NCOA3 RNF213 CHD7

4.27e-0517749482fdd6185b368f54f03de389427cbe3071d21a99
ToppCellControl-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL4A3 CECR2 PRSS22 ME1

4.27e-051774949af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL4A3 ADAM33 CHD7 SHISA8

4.56e-05180494c6030e725e3d86d5d74a1676330c77ffeceb324f
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL4A3 CECR2 PRSS22 ME1

4.66e-05181494b45b11428d13950369347e051d4d517efb2bd4fd
ToppCellControl-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL4A3 CECR2 PRSS22 ME1

4.76e-05182494a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCellSomatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL4A3 CECR2 NTN1 CHD7

4.76e-051824948a8b08ac4bb3cba3541dbe234e088703842285b9
ToppCellSomatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL4A3 CECR2 NTN1 CHD7

4.76e-05182494e36766309c4d96a90d213ce37d3acef1029a3fdc
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL4A3 CECR2 PRSS22 ME1

4.86e-05183494ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCellE15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

COL4A3 UPK3B ADAM33 ILVBL

4.86e-05183494274f274cf60daa30d6a4cd603a3af7823bfb8016
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL4A3 CECR2 PRSS22 ME1

4.97e-0518449442ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL4A3 CECR2 PRSS22 ME1

4.97e-051844947cc5796557379c3d1db078c1aeda40659c6e401c
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL4A3 CECR2 PRSS22 ME1

4.97e-05184494cdf6f1c6cce97a7effa0c55959652e2c0b6992b3
ToppCellfacs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCC9 ADAM33 NTN1 OLFML3

5.07e-051854948433a337625ff8398520e223ef92bf9bb0beb14c
ToppCellfacs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCC9 ADAM33 NTN1 OLFML3

5.07e-05185494049d793d043d5d434f143025de49dd210d18756c
ToppCellfacs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCC9 ADAM33 NTN1 OLFML3

5.07e-0518549463200c42565eea596f9b00728e70e544b8d50a7f
ToppCellControl-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL4A3 CECR2 PRSS22 ME1

5.07e-051854943937e026add96a396122139daf8011cfbc60e75c
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL4A3 CECR2 PRSS22 ME1

5.07e-05185494c82eab551f65ecebe6db908eda9f9eb3414693c7
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

COL4A3 NCOA3 CHD7 SHISA8

5.18e-0518649455b239834b96b1f7787ec77a7d19796d617bbbf0
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL4A3 CECR2 PRSS22 ME1

5.18e-051864943aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCellPrimary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL4A3 CECR2 NTN1 CHD7

5.29e-05187494daff7ccd3f1924cf2b34d3aca3eccde245aaf371
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL4A3 CECR2 PRSS22 ME1

5.29e-0518749458d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCellPrimary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL4A3 CECR2 NTN1 CHD7

5.29e-051874945b7a1edee602e55d3400dc17dbb6b8aaa26defc0
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

COL4A3 NCOA3 CHD7 SHISA8

5.40e-051884946f53bcd4caab2fc961af799039ea5c3ddae56781
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_memory|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

COL4A3 NCOA3 CHD7 SHISA8

5.74e-0519149403f6da73e7b706252d2096507222229c4101a27b
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_memory-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

COL4A3 NCOA3 CHD7 SHISA8

5.74e-05191494578b58782e816ecaeabfbc616ceb1dcd53ee428b
ToppCellfacs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

APLN NTN1 LTBP3 OLFML3

5.74e-051914949214655dca96d766737c9f30b624d7fe7050342e
ToppCell(5)_Epi_upper|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)

UPK3B TMPRSS11D PRSS22 MYEOV

5.86e-051924940c8f73cfd24531a040544df39f28626433aaa651
ToppCell(5)_Epithelial_cells-(5)_Epi_upper|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)

UPK3B TMPRSS11D PRSS22 MYEOV

5.86e-0519249469b6b3ceaad6432c46d1bc2a00b8389069a8876e
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_intermediate|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

COL4A3 NCOA3 CHD7 SHISA8

5.98e-051934947cc10e8b51091869d46e462f3214999e7b5348b1
ToppCellmild_COVID-19-B_memory|mild_COVID-19 / disease group, cell group and cell class (v2)

COL4A3 NCOA3 CHD7 SHISA8

5.98e-051934947e6fe70928a50b0a8f12220e572c07c5670d092e
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_intermediate|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

COL4A3 NCOA3 CHD7 SHISA8

6.10e-051944942b61023a602d336ed0de174e9141046173db34e6
ToppCelldroplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GLI2 ABCC9 LTBP3 OLFML3

6.10e-051944947826fe5eb254ac032de0d978f39585a40e0b3ee4
ToppCellCOVID-19_Mild-Lymphoid_B-B_intermediate|COVID-19_Mild / Disease group, lineage and cell class

COL4A3 NCOA3 CHD7 SHISA8

6.10e-05194494bf6f72a489c62cbf1a679552d8c5eaaaa0b99d33
ToppCellPBMC-Control-Lymphocyte-B|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

COL4A3 NCOA3 CHD7 SHISA8

6.10e-05194494a8daf73c186a15adb9ea02793d4bd9cb35c66290
ToppCellPBMC-Control-Lymphocyte-B|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

COL4A3 NCOA3 CHD7 SHISA8

6.10e-0519449439121c7d537ac103f6959271d814fd327be7114f
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

COL4A3 NCOA3 CHD7 SHISA8

6.10e-05194494f2486b19ac52a48d19f80b38a5536bee3dad745b
ToppCellP28-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ANKRD35 ABCC9 ADAM33 LTBP3

6.10e-051944943c661c6768c3f05d2aba03d329adb257ca201b2d
ToppCellPBMC-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

COL4A3 NCOA3 CHD7 SHISA8

6.10e-0519449460542304899b99caa38e4abf6b71ba986fa6c399
ToppCelldroplet-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCC9 ADAM33 LTBP3 ME1

6.22e-05195494d32716a12014522492becbde1088dc1106308490
ToppCell5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ACSL4 ABCC9 ADAM33 OLFML3

6.22e-05195494fc43cd295f2cc3f6e9442232e028944f011c82cc
ToppCelldroplet-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCC9 ADAM33 LTBP3 ME1

6.22e-05195494b913d5df50c88a3a255f516a1aa42419c6701e1e
ToppCellParenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

GLI2 ADAM33 CFAP418 OLFML3

6.35e-05196494614a07334707eafe238d5cb7b080a3ca796a1920
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_B-Memory_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue

COL4A3 NCOA3 CHD7 SHISA8

6.35e-05196494c450cd6b799932f5cce8326d1079114abeb71e95
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_B|lymph-node_spleen / Manually curated celltypes from each tissue

COL4A3 NCOA3 CHD7 SHISA8

6.47e-051974949837bd2cc28b79147fb5d1997631ef953fd020e4
ToppCell5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ACSL4 ABCC9 ADAM33 OLFML3

6.47e-05197494ab5d3ebc73bd7cfc64381d14b92878b370205186
ToppCellmild_COVID-19-B_intermediate|mild_COVID-19 / disease group, cell group and cell class (v2)

COL4A3 NCOA3 CHD7 SHISA8

6.47e-05197494f669500120646f69355a6f920b892a6f2faeab63
ToppCell5'-Adult-Appendix-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ACSL4 ABCC9 ADAM33 OLFML3

6.47e-05197494b11a5d909942a4299cbc0b27332b1a3f66f3bccd
ToppCellNon-neuronal-Postmitotic-Mural-Mural|World / Primary Cells by Cluster

CD93 APLN ABCC9 OLFML3

6.60e-051984949fc1035ea447a4551a66944c869c4671e17cec61
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

UPK3B TMPRSS11D PRSS22 MYEOV

6.60e-0519849472d91bd0c727ecadc41e023a16c9326158db1b7b
ToppCellNon-neuronal-Postmitotic-Mural|World / Primary Cells by Cluster

CD93 APLN ABCC9 OLFML3

6.60e-05198494dd38840a96171f58da243daa22b013e15a81db4a
ToppCelldistal-mesenchymal-Fibromyocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ANKRD35 GLI2 ADAM33 NTN1

6.60e-051984949d1d95e7703cfc70a8ad427e400c340dbd205db8
ToppCellControl_saline-Epithelial_alveolar-AT_1-AT1|Control_saline / Treatment groups by lineage, cell group, cell type

COL4A3 UPK3B LTBP3 ME1

6.60e-051984949f972f217d2c39d4c0f7d0d4227d0fffe8535b9d
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

UPK3B TMPRSS11D PRSS22 MYEOV

6.60e-05198494441608034c787e55691558a480dcd07e37419138
ToppCellNon-neuronal-Postmitotic-Mural-Mural-18|World / Primary Cells by Cluster

CD93 APLN ABCC9 OLFML3

6.60e-0519849421efb7bcd24f24d20791b34e75d6f9d46a129481
ToppCelldistal-mesenchymal-Fibromyocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ANKRD35 GLI2 ADAM33 NTN1

6.60e-05198494fbfac1d10e4224990a094cc84b74bbc206881423
ToppCellNon-neuronal-Postmitotic-Endothelial|World / Primary Cells by Cluster

CD93 APLN ABCC9 OLFML3

6.73e-05199494b9763ac9857a60db6f1f104fe1e9ea2266cf931b
ToppCellNon-neuronal-Postmitotic-Endothelial-Endothelial-24|World / Primary Cells by Cluster

CD93 APLN ABCC9 OLFML3

6.73e-051994940b4edf3e359749827ef978a77b5267ddde732d71
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

COL4A3 CHD7 LTBP3 ME1

6.73e-05199494d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCellNon-neuronal-Postmitotic-Endothelial-Endothelial|World / Primary Cells by Cluster

CD93 APLN ABCC9 OLFML3

6.73e-051994949e01eee126247a0696c71b019f855a8a41a0ede3
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PRSS38 GBE1 LTBP3 TSPYL4

6.73e-0519949485bb28369e0568b7b3bda095722102fc793f60ef
ToppCellBronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

ANKRD35 GLI2 ADAM33 OLFML3

6.73e-0519949421335475bbfbad8a6943b8076a6c1c67f3eec5d3
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-HS3ST3A1|Neuronal / cells hierarchy compared to all cells using T-Statistic

APLN ADAM33 CHD7 SHISA8

6.86e-05200494dd68ce6934eafb75d918042fcf7fd7a750294b7f
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1-L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic

CECR2 ADAM33 CHD7 SHISA8

6.86e-052004942086024ce808b8796ed508a229b098eb02f8828a
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

COL4A3 CHD7 LTBP3 ME1

6.86e-052004948683445ad5b70748c4a1f12eb77d47623085147e
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1|Neuronal / cells hierarchy compared to all cells using T-Statistic

CECR2 ADAM33 CHD7 SHISA8

6.86e-0520049435951db6a4f442ac9e13f1b8cc5b4a33481f92c8
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-HS3ST3A1-L3-6|Neuronal / cells hierarchy compared to all cells using T-Statistic

APLN ADAM33 CHD7 SHISA8

6.86e-0520049406ea96428728199a30a0f836647d6448287d3848
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL4A3 UPK3B DHRS13

2.29e-04108493d620f07243c2628494e689bbfabc14c453f4b1f4
ToppCellFrontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Reln_(Cajal-Retzius)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

ANKRD35 KRT79 DNAH1

2.82e-041164931bfd3b0ec4cb5a04c6dfe7861a544eb277e473a3
ToppCellFrontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Reln_(Cajal-Retzius)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

ANKRD35 KRT79 DNAH1

2.82e-04116493a3dcd18807d14e207438f321be62797384fd3907
ToppCellFrontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

ANKRD35 KRT79 DNAH1

2.82e-04116493685484ea4cbefb5aff5f0cd999fdfadc5a5676e1
ToppCellControl-Endothelial-Endothelial-Activated_Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CD93 COL17A1 CHSY1

3.19e-04121493a5962d1c476e6966870832b72d511607e047248b
ToppCell343B-Epithelial_cells-Epithelial-E_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells)

COL4A3 GLI2 C1orf167

5.42e-0414549380684ec249fa445c1b35f94608a4a6824d53f2d9
ToppCell343B-Epithelial_cells-Epithelial-E_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells)

COL4A3 GLI2 C1orf167

5.42e-04145493cb534333fba44b241b14fb0d7b74e843f4e7f9f8
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NTN1 CASTOR2 INCA1

5.53e-04146493ec1f793409d1a81c0f9323eb3c82ffe01dae0e44
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

OSBPL7 RASGEF1A ME1

5.98e-041504936785b695a01de47a47f5c94fdc432428ef80bada
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

OSBPL7 RASGEF1A ME1

5.98e-04150493ddfb7dd696f06e834c45d6c3f9b1138bc17d62b3
ToppCellBAL-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

COL4A3 CD93 OLFML3

6.10e-041514930b6b37734430918378ed94e40877f0c4ae9b25ec
ToppCellBAL-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

COL4A3 CD93 OLFML3

6.10e-0415149330225a1a7800b0ae19e16ac164f561379eedb99d
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3-6_VIP_KCTD13|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL4A3 NTN1 SHISA8

6.10e-041514931fd43cda3ac4d1c96560338fcfb6c346b1dec0a2
ToppCellP07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

COL4A3 DNAH1 PM20D2

6.33e-041534935501095bcf73080872ae01128f21399f9cfc5dd1
ToppCellTransplant_Alveoli_and_parenchyma-Epithelial-Basal_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X

COL17A1 PRSS22 NTN1

6.33e-04153493a44da11a913b19edde6c5d1d6e625c24b20ecbfd
ToppCell343B-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

GLI2 ADAM33 OLFML3

6.33e-04153493d5f5399ebbbff508c96ce7f01272716b61597ab5
ToppCell343B-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

GLI2 ADAM33 OLFML3

6.33e-0415349332cf4ca828d228f23366480305592f9813fed7ff
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

COL17A1 ALKBH7 OLFML3

6.33e-04153493099382241971412f84b6feefb897360a74a41143
ToppCellP28-Epithelial-epithelial_progenitor_cell-epi_progenitor|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ACSL4 CHSY1 ME1

6.58e-04155493be575a0096415705dba425002247289ff8f89474
ToppCellPBMC-Mild-cDC_6|Mild / Compartment, Disease Groups and Clusters

COL17A1 MYEOV OLFML3

6.70e-041564933db686849844120b3e376599929d11ad06f0d577
ToppCellfacs-Lung-EPCAM-24m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TSPOAP1 UPK3B PRSS22

6.83e-04157493d2cb261a9ee2c90e2e0fc656bd6413fbccb465fc
ToppCellfacs-Lung-EPCAM-24m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TSPOAP1 UPK3B PRSS22

6.83e-04157493350069e4d2dbddc82e813e2a2cc43032daa23605
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL4A3 PRSS22 ME1

6.83e-041574939665a1375cfd8e9b8781c852686591226c0e0d9a
Diseaselevel of complement component C1q receptor in blood serum

COL4A3 CD93

3.55e-056462OBA_2040369
DiseaseAmelogenesis Imperfecta

COL17A1 LTBP3

1.55e-0412462C0002452
Diseasealbuminuria

COL4A3 CHD7 BAHCC1

4.30e-0494463EFO_0004285
Diseasegranulocyte count

ANKRD35 HECTD4 CHSY1 CHD7

6.59e-04254464EFO_0007987
Diseasemonocyte percentage of leukocytes

TSPOAP1 CECR2 ETFDH CHSY1 CHD7 BAHCC1

9.12e-04731466EFO_0007989

Protein segments in the cluster

PeptideGeneStartEntry
IAGMTGQCERIPGLG

ACSL4

296

O60488
QGPRGEQGLTGMPGI

COL17A1

751

Q9UMD9
MRGGAEGQPCLPGGD

BRAT1

176

Q6PJG6
SCAGGMLGRPGTGVV

BAHCC1

301

Q9P281
QVPGSGMAALGGCPR

C1orf167

1356

Q5SNV9
MGIRGDQGRDGIPGP

COL4A3

1151

Q01955
MVRIGGQPLGFDECG

CASTOR2

266

A6NHX0
GMCRPLALGGPGQVT

CD93

186

Q9NPY3
LLRRGMVEQPKGCGG

CFAP418

21

Q96NL8
GLGLVEPGTQCGPRM

ADAM33

621

Q9BZ11
CGGSLMPLPDGNGLE

APLN

21

Q9ULZ1
PTGQLTMIVGQVGCG

ABCC9

696

O60706
SLRPGGDGMEQGCPK

ANKRD35

361

Q8N283
LTGHMRPNGCPGVGL

CHD7

471

Q9P2D1
GPRLGTPEEKQMCGG

CECR2

701

Q9BXF3
ACLVGAVRGGPGLSM

NTN1

16

O95631
TEMCQGGDPGSGLRP

TSPOAP1

1216

O95153
PGRPGGGGEMENTLQ

OLFML3

226

Q9NRN5
ILGLGDLGCNGMGIP

ME1

156

P48163
MGQGAGRQTFGPACP

KRT79

96

Q5XKE5
LLGPGSQNSMGAGPC

KCNH6

761

Q9H252
MVVSGAPPALGGGCL

PRSS22

1

Q9GZN4
PGRGLLAGAGALCMT

MYEOV

206

Q96EZ4
NVGPSAPMLGGCQLG

GLI2

1116

P10070
APMLGGCQLGFGAPS

GLI2

1121

P10070
CGRPSMEGKILGGVP

PRSS38

51

A1L453
LQGGPRIEELTCGGM

HECTD4

1226

Q9Y4D8
PQIGGEGMRGAGLSC

NSUN6

401

Q8TEA1
DINFVCAMGPPGGGR

DNAH1

2336

Q9P2D7
GGLLIGCSPGFMNVP

ETFDH

381

Q16134
GMPALCSPISQGGGG

GBE1

416

Q04446
LGVPCFLGGMARGLL

ILVBL

311

A1L0T0
MVTPAGCLGGRNQGP

CYP4F30P

1

Q9H0H9
QRGEDGMCAGPLAGP

LTBP3

1141

Q9NS15
MARVGPGRAGVSCQG

EME2

1

A4GXA9
NGMPLPGGGTLRTCV

SDR42E2

191

A6NKP2
PPCGGMGNLRGRTAV

DHRS13

26

Q6UX07
ERCQKGGCVPGRPMG

OSBPL7

446

Q9BZF2
PCLEGMQQQGLGGVP

INCA1

96

Q0VD86
GIRPPMAGCNSSVGG

NCOA3

386

Q9Y6Q9
LGPPLGGCVQVQMGD

SHISA8

196

B8ZZ34
VGGVCTGLGMPPQNV

ADSS2

276

P30520
MRPGGERPVEGGACN

PM20D2

1

Q8IYS1
ICRSLPEGMGPGESG

ALKBH7

201

Q9BT30
ALEPGENFCMGGPGV

CHSY1

211

Q86X52
AILSGMLCAGVPQGG

TMPRSS11D

346

O60235
GMGGSPVERCLPRGL

RNF213

1811

Q63HN8
ILGPSCSGQVQPGMG

RASGEF1A

11

Q8N9B8
LEACGAGGLGSQMIP

TSPYL4

131

Q9UJ04
CGDPMAGSGGAPVLR

UPK3B

171

Q9BT76